|
|
News - dystrophin
Halo Therapeutics Raises $1.1M To Expedite Phase 2 Study Of HT-100
23 May 2012, 2:48 am
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that it has received financial support totaling $1.1 million from 12 not-for-profit foundations serving the muscular dystrophy patient community.
What is muscular dystrophy?
20 May 2012, 2:10 am
Muscular dystrophies are inherited genetic disorders that cause progressive muscular deterioration and declining muscle strength. Duchenne muscular distrophy — the type Ryan Sutherland has — is one of the most deadly. Symptoms begin to show up at age 3 or 4. The child loses the ability to walk usually between the ages of 7 and 12. By early teens, the heart and respiratory muscles can be affected ...
Grandpa walks in honour of grandson
15 May 2012, 8:59 am
A grandfather can be a wonderful thing, a teacher, a friend, a fellow adventurer. For four-year-old Louie Facca a grandpa is a source of hope.
Iranian researcher helps treating muscular dystrophy using stem cells
6 May 2012, 1:03 pm
Iranian researcher and lecturer Radbod Darabi jointly with his collogues from the University of Minnesota's Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells derived from a new process which for the first time makes the production of human muscle cells from stem cells efficient and effective.
Biotech Stock Mailbag: AVI, Aveo, Spectrum
27 April 2012, 5:10 am
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies. Click to view a price quote on AVII . Click to research the Drugs industry.
|
|
